IDDI Experience

Customized Solutions Adapted To Your Therapeutic Areas

All therapeutic areas face specific challenges, from patient populations to endpoints, assessment instruments and other strict study design requirements. If those needs aren’t properly understood, your goals will not be met.

Therefore, it is crucial to partner with an experienced contract research organization that has a solid understanding of the clinical development process and breadth of therapeutic areas expertise.

Customized Solutions Therapeutic Areas
Submit RFI
  • Our valuable therapeutic insight in cancer research and ophthalmology, paired with data quality expertise, will make a critical difference to the outcome of your clinical trials.
  • Our scientific background, experienced teams and in-house therapeutic expertise will provide you with effective study design, start-up and management.
  • IDDI’s broad range of expertise is reflected in its expert publications in various medical and statistical journals and through its presence at major meetings and congresses (list provided on request).
  • IDDI’s in-depth experience had been gained from involvement in over 1330 clinical trials across a wide range of therapeutic areas – handling drug, diagnostic and medical device issues, as well as assisting clients in obtaining 21 FDA/EMA approvals.
1335
Phase I-IV clinical trials
950
Scientific publications
4
Papers quoted in FDA guidance
50
Scientific webinars

Experience in the Main Therapeutic Areas

IDDI’s main therapeutic area of expertise is cancer research, with substantial experience in ophthalmology, cardiovascular , CNS diseases and orphan diseases.

IDDI Experience

Global Therapeutic Experience

CANCER RESEARCH

Involvement in 15 Market Approvals

840+ Trials

OPHTHALMOLOGY

IDDI supported Macugen® approval

160+ TRIALS

ORPHAN DISEASES

109+ TRIALS

CARDIOLOGY

59 TRIALS

CENTRAL NERVOUS SYSTEM (CNS)

61 TRIALS

MUSCULOSKELETAL

35 TRIALS

MEDICAL DEVICES

  • Our processes conform to medical device studies, both for pilot and pivotal studies
  • We help our clients achieve the European Conformity CE marking and FDA approvals for medical devices.
  • IDDI has successfully helped a cardio-vascular device approval in the US, and validation of a cancer diagnostics product also submitted to the FDA.

TALK TO AN EXPERT

Breakdown of Trials by Therapeutic Area (number of trials over the last five years):